Clinical Trial Update: Bufei Yishen Granule for Reducing Acute Exacerbation in GOLD Stage 3 or 4 COPD [Phase 3]

View source ↗

Summary

A Phase 3 trial update on Bufei Yishen Granule for reducing acute exacerbations in COPD patients (GOLD stage 3-4).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Bufei Yishen Granule

Snippet

Sponsor: Henan University of Traditional Chinese Medicine | Conditions: Chronic Obstructive Pulmonary Disease | Phase 3 | Status: UNKNOWN